IG Guidelines | Version in Use (Year) | Organization Committee | Number of Indications | IVIG Dose Calculatord | Disclaimer of Dose Calculator | Home Infusion Program | Materials Included |
---|---|---|---|---|---|---|---|
Ontario | V4, 2018 | The Ontario Regional Blood Coordinating Network (ORBCoN) | 37 | Yes | The dose calculator is intended to be used when determining the dose of IVIG for clinically obese patients; it is not recommended for pediatric patients or any patients (including adults) under 5ft in height. The dosing information recommended in the IVIG Utilization Management guidelines should be followed for other patients | Yes | Recommendation categories; Dosing; IG request forms; Infusion guide and adverse reaction chart; Information for outpatients; Documentation for travel |
Prairies (Alberta, Saskatchewan, Manitoba) | V2, 2022 | The Inter-Provincial Medical Expert Committee and the Institute of Health Economics (IHE) | 143 | Yesa | Same as the Ontario calculator, with the following additional information: Height must be 153–241 cm (60–95 inches). Weight must be 20–400 kg (44–882 pounds) | Yes (AB) | Recommendation categories; Dosing; SCIG administration; Frequency of follow-up and assessment of effectiveness; Instructions for weaning patients off IG, Off-label use; Vaccinations; Adverse effects |
Atlantic (New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador) | V2, 2022 | The Atlantic Blood Utilization Strategy (ABUS) Working Group | 74 | Yesc | Use the dose calculator if the patient is over 152.4Â cm in height and over 50Â kg for males/45.5Â kg for females | Yes | Recommendation categories; Dosing; SCIG administration |
British Columbia | V5, 2019 | The BC Provincial Blood Coordinating Office (PBCO) | 25 | Yes | Separate IVIG dose calculations for adults (18Â years old and over), children (under 18Â years old), and pregnant women. A dose calculator for SCIG is also available | Yes | Recommendation categories; Dosing |
Québec | 2017–2022 | The Institut national d’excellence en sante et en services sociaux (INESSS) | 165 | Yesb | N/Ab | No | Recommendation categories; Dosing; Frequency of administration; Adverse reactions; Relative contraindications; Main precautions |